ID   KIM-1
AC   CVCL_7969
DR   Wikidata; Q54899926
RX   DOI=10.2957/kanzo.25.532;
RX   PubMed=7537711;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   HLA typing: A*11:01,26:03; B*15:01,67:01; C*03:03,07:02; DQA1*01:02,03:01; DQB1*04:01,05:02; DRB1*04:05,16:02 (PubMed=9178645).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   DOI=10.2957/kanzo.25.532;
RA   Murakami T.;
RT   "Establishment and characterization of human hepatoma cell line (KIM-1).";
RL   Acta Hepatol. Jpn. 25:532-539(1984).
//
RX   PubMed=7537711; DOI=10.1002/hep.1840210510;
RA   Haramaki M., Yano H., Fukuda K., Momosaki S., Ogasawara S., Kojiro M.;
RT   "Expression of CD44 in human hepatocellular carcinoma cell lines.";
RL   Hepatology 21:1276-1284(1995).
//
RX   PubMed=9178645; DOI=10.1006/cimm.1997.1108;
RA   Nakao M., Sata M., Saitsu H., Yutani S., Kawamoto M., Kojiro M.,
RA   Itoh K.;
RT   "CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with
RT   hepatocellular carcinoma.";
RL   Cell. Immunol. 177:176-181(1997).
//
RX   PubMed=10347112; DOI=10.1002/hep.510290624;
RA   Yano H., Iemura A., Haramaki M., Ogasawara S., Takayama A., Akiba J.,
RA   Kojiro M.;
RT   "Interferon alfa receptor expression and growth inhibition by
RT   interferon alfa in human liver cancer cell lines.";
RL   Hepatology 29:1708-1717(1999).
//
RX   PubMed=27329724; DOI=10.18632/oncotarget.10161; PMCID=PMC5216950;
RA   Watari K., Nishitani A., Shibata T., Noda M., Kawahara A., Akiba J.,
RA   Murakami Y., Yano H., Kuwano M., Ono M.;
RT   "Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy
RT   of rapalogs for treating hepatocellular carcinoma.";
RL   Oncotarget 7:47403-47417(2016).
//